1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. JD Health International Inc.
  6. Summary
    6618   KYG5074A1004

JD HEALTH INTERNATIONAL INC.

(6618)
  Report
Delayed Hong Kong Stock Exchange  -  03:59 2022-08-19 am EDT
59.60 HKD   -1.81%
07/01JD Health to Buy Pet Care Assets From JD.com For $355 Million
MT
06/22Beijing Mulls Banning Internet Healthcare Firms From Selling Drugs Online
MT
06/22Hong Kong Stocks Snap Three-Day Rally; Mega Genomics Wipes Out Early Gains in Debut
MT
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Hong Kong Stock Exchange
08/15/2022 08/16/2022 08/17/2022 08/18/2022 08/19/2022 Date
62.65(c) 61.45(c) 61.2(c) 60.7(c) 59.6 Last
3 461 601 2 721 275 2 778 694 3 038 376 2 515 103 Volume
+1.62% -1.92% -0.41% -0.82% -1.81% Change
More quotes
Estimated financial data (e)
Sales 2022 42 866 M 6 317 M 6 317 M
Net income 2022 510 M 75,2 M 75,2 M
Net cash position 2022 23 966 M 3 532 M 3 532 M
P/E ratio 2022 347x
Yield 2022 -
Sales 2023 58 388 M 8 604 M 8 604 M
Net income 2023 1 296 M 191 M 191 M
Net cash position 2023 26 299 M 3 875 M 3 875 M
P/E ratio 2023 128x
Yield 2023 -
Capitalization 167 B 24 593 M 24 593 M
EV / Sales 2022 3,33x
EV / Sales 2023 2,41x
Nbr of Employees 3 305
Free-Float 32,0%
More Financials
Company
JD Health International Inc is a China-based investment holding company principally engaged in the Internet + Healthcare ecosystem business. The Company mainly providing pharmaceutical and healthcare products and Internet healthcare, health management, intelligent healthcare solutions to the customers, as well as a variety of marketing services to the business partners. The Company mainly conducts its businesses in... 
Sector
Department Stores
Calendar
08/23Earnings Release
More about the company
Ratings of JD Health International Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about JD HEALTH INTERNATIONAL INC.
07/01JD Health to Buy Pet Care Assets From JD.com For $355 Million
MT
06/22Beijing Mulls Banning Internet Healthcare Firms From Selling Drugs Online
MT
06/22Hong Kong Stocks Snap Three-Day Rally; Mega Genomics Wipes Out Early Gains in Debut
MT
06/22China shares fall on economic outlook, HK down on signs of tech crackdown
RE
06/22Chinese Online Health Companies Extend Losses Amid Sector Sell-Down
DJ
06/01JD HEALTH INTERNATIONAL : Next Day Disclosure Return
PU
05/05JD Health's Latest Share Buyback Fails to Recover Losses; Shares Slump 5%
MT
05/04Hong Kong stocks fall as tech shares drag ahead of Fed rate decision
RE
05/04Hong Kong Stocks Fall as Economy Shrinks; JD Health Tumbles 13%
MT
05/04Hong Kong stocks down as tech shares slide ahead of Fed rate decision
RE
04/26JD HEALTH INTERNATIONAL : Next Day Disclosure Return
PU
04/14IFlytek Denies Rumored Layoffs
MT
04/11UBS Adjusts JD Health International's Price Target to HK$70 From HK$138, Keeps at Buy
MT
04/07China stocks end lower as COVID worries outweigh stimulus promises
RE
04/06JD Health International Inc. Announces Board Changes
CI
More news
News in other languages on JD HEALTH INTERNATIONAL INC.
06/22Pékin envisage d'interdire aux entreprises de soins de santé sur Internet de vendre des..
06/22Les actions de Hong Kong rompent leur rallye de trois jours ; Mega Genomics efface les ..
05/04Les actions de Hong Kong chutent en raison de la contraction de l'économie ; JD Health ..
05/04Point marchés-Peu de changements en vue en Europe en attendant la Fed (actualisé)
04/14IFlytek dément les rumeurs de licenciements
More news
Analyst Recommendations on JD HEALTH INTERNATIONAL INC.
More recommendations
Chart JD HEALTH INTERNATIONAL INC.
Duration : Period :
JD Health International Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JD HEALTH INTERNATIONAL INC.
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 20
Last Close Price 52,51 CNY
Average target price 71,89 CNY
Spread / Average Target 36,9%
EPS Revisions
Managers and Directors
Enlin Jin Chief Executive Officer & Executive Director
Dong Cao Chief Financial Officer
Qiang Dong Liu Chairman
Xing Yao Chen Independent Non-Executive Director
Ling Li Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
JD HEALTH INTERNATIONAL INC.-1.22%24 593
AMAZON.COM, INC.-14.65%1 449 689
JD.COM, INC.-21.24%84 323
COUPANG, INC.-39.86%31 217
ETSY, INC.-47.73%14 490
MONOTARO CO., LTD.29.52%9 872